Cannara Biotech Inc LOVFF
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $1.44
- Day Range
- $1.44–1.44
- 52-Week Range
- $1.11–1.66
- Bid/Ask
- $0.01 / $221.56
- Shares Outstanding
- 98.78M
- Market Cap
- $142.25M
- Volume/Avg
- 7,500 / 8,603
Key Statistics
- Price/Earnings (Normalized)
- 15.01
- Price/Sales
- 1.64
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Cannara Biotech Inc is a vertically integrated producer of premium-grade cannabis and cannabis-derivative products for Canadian markets. The company owns two mega Quebec-based facilities. The company operates in in two segments; Indoor cannabis operations segment which includes the cultivation, processing and sale of dried cannabis and cannabis derivatives for the Canadian market and the Real estate operations segment related to the Farnham and Valleyfield building. Majority of the revenue for the company is generated from its Cannabis operations segment. .
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Core
- Total Number of Employees
- 363
- Website
- http://www.cannara.ca
Valuation
|
Metric
|
LOVFF
|
|---|---|
Price/Earnings (Normalized) | 15.01 |
Price/Book Value | 1.56 |
Price/Sales | 1.64 |
Price/Cash Flow | 7.16 |
Price/Earnings
LOVFF
Financial Strength
|
Metric
|
LOVFF
|
|---|---|
Quick Ratio | 1.24 |
Current Ratio | 3.00 |
Interest Coverage | 7.69 |
Quick Ratio
LOVFF
Profitability
|
Metric
|
LOVFF
|
|---|---|
Return on Assets (Normalized) | 7.47% |
Return on Equity (Normalized) | 11.89% |
Return on Invested Capital (Normalized) | 9.69% |
Return on Assets
LOVFF
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Merck KGaA ADR
MKKGY
| LOCK|bzJh>qj | LOCK|b%D& | $70B | |||
| Teva Pharmaceutical Industries Ltd
TEVA
| LOCK|%<^<JZR | LOCK|&$Ml$ | $46B | |||
| Haleon PLC ADR
HLN
| LOCK|JqyzBB | LOCK|l< | $45B | |||
| Zoetis Inc Class A
ZTS
| LOCK|BbKgr>B | LOCK|<! | $33B | |||
| Viatris Inc
VTRS
| LOCK|C!^!JMH | LOCK|b<& | $21B | |||
| Elanco Animal Health Inc
ELAN
| LOCK|JCD | LOCK|!Wr | $11B | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| LOCK|tswxV# | LOCK|<Rr | $11B | |||
| Hims & Hers Health Inc Ordinary Shares - Class A
HIMS
| LOCK|&BfN@h | LOCK|Kl | $6B | |||
| Prestige Consumer Healthcare Inc
PBH
| LOCK|RN$>?d | LOCK|%!Nk | $2B | |||
| Perrigo Co PLC
PRGO
| LOCK|CldZ&$ | LOCK|$jS | $2B |
United States